Novartis AG

Swiss-American multinational pharmaceutical corporation

NVS NYSE SEC CIK 1114448

Follow Novartis Weekly email: filings, results, news

News

46 stories filed under Novartis, grouped into ongoing threads

Drug

Thread · 4 stories

Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%

Markets 16 d ago also on AMGN

Novartis’s failed trial for cholesterol drug leads to broad biopharma stock selloff

Markets 16 d ago

Novartis twin drug setbacks pile pressure on pipeline and CEO

Markets 16 d ago 2 sources

Novartis RNA drug falls short in rare muscle disease study

Deals 16 d ago also on RNA

European

Thread · 4 stories

European Stocks Muted as Oil Prices Climb and Novartis Falls

Markets 16 d ago 2 sources also on AG

European shares dip on oil-led inflation woes; Novartis set for worst day on record

Economy 16 d ago

European Stocks Muted as Novartis Shares Fall Most on Record

Markets 16 d ago also on AG

European shares dip as higher crude revives inflation worries; Novartis drags

Economy 16 d ago

Trial

Thread · 4 stories

Dyne Therapeutics Remains A Buy Even As Novartis Trial Failure Hits DM1 Class

Markets 15 d ago also on DYN

STAT+: Pharmalittle: We’re reading about another Novartis trial failure, a Novo Nordisk setback, and more

Markets 16 d ago

Amgen Shares Fall as Investors Assess Novartis Lp(a) Trial Result and BMO Downgrade

Markets 16 d ago also on BMO AMGN

Novartis shares sink on latest trial setback

Markets 16 d ago

More coverage

BoomRay and Novartis Pharma sign $900m deal for radioligand therapy

Markets 1 d ago

Deutsche Bank downgrades Novartis to Hold after second clinical setback

Markets 15 d ago

Novartis and Boston Scientific Slide, Intel Price Hikes | Stock Movers

Markets 16 d ago 2 sources also on BSX INTC

Why is Novartis stock sliding today?

Markets 16 d ago 2 sources

Novartis Is Having a Very Bad September—and More Pain Could Be on the Way

Markets 16 d ago

Novartis initiates phase 2 study of MRT-6160 for Sjögren’s disease

Markets 16 d ago also on MRT

Attacks Halt Saudi Energy Sites, Novartis Drops Most in 6 Years | The Opening Trade 9/8/2026

Markets 16 d ago

Why is Novartis stock tumbling today?

Markets 16 d ago 2 sources

Novartis Sees Avidity Drug Suffer Third Clinical-Trial Setback

Deals 16 d ago

Novartis India acquires Pfizer brands for $132m

Deals 16 d ago also on PFE

Novartis shares plunge 10% as failed drug trial clouds growth outlook

Markets 16 d ago

Why is Novartis stock tumbling today?

Markets 16 d ago

Profile

Headquarters: BASEL
Founded: 1996
CEO: Vasant Narasimhan
Employees: 119,418
Sector: Healthcare
Industry: Pharmaceutical Preparations
Website: novartis.com

Peers

Where this page comes from

Profile · SEC EDGAR, Wikidata

News · 46 stories clustered from the RSS aggregator